Impact of Airborne Pathogen Inactivation Devices Using UVGI Against Respiratory Diseases Affecting Retirement Home Residents

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
RESPROTECT is a RIPH2 category research, prospective, interventional, multicenter, double-blind, cluster-randomized versus placebo device and cross-over. It\'s main objective is to compare the cumulative incidence of upper and lower respiratory infections between retirement homes (EHPAD) equipped with active UVGI systems and retirement homes (EHPAD) equipped with inactive systems over two winter periods.
Epistemonikos ID: 4a94be28de21c05c17242818399100ff8755d14f
First added on: Apr 17, 2025